Cholecystokinin Receptor
Cholecystokinin (CCK) is a neuropeptide that affects growth rate in chickens by regulating appetite. CCK peptides exert their function by binding to two identified receptors, CCKAR and CCKBR in the GI tract and the brain, respectively, as well as in other organs. In mammals, CCK/CCKAR interactions affect a number of immunological parameters, including regulation of lymphocytes and functioning of monocytes.
CCK, also known as pancreozymin, is synthesized and secreted by enteroendocrine cells in the duodenum. The main function of CCK is to cause the release of digestive enzymes and bile from the pancreas and gallbladder, respectively. It also induces drug tolerance to opioids like morphine and heroin. Cholecystokinin (CCK) has strong bioactivity in the regulation of a number of cell activities.
Targets for Cholecystokinin Receptor
Products for Cholecystokinin Receptor
- Cat.No. Product Name Information
-
GC31558
CCK-A receptor inhibitor 1
-
GC30752
CCK-B Receptor Antagonist 1
-
GC38746
CCK-B Receptor Antagonist 2
-
GC30008
Ceruletide (Caerulein)
A cholecystokinetic agent and cholecystokinin receptor agonist
-
GC30674
CHEMBL333994 (FK-480)
-
GC18139
Devazepide
CCK1 (CCK-A) receptor antagonist, orally active
-
GC35846
Dexloxiglumide
-
GC15133
Gastrin I (human)
Selective CCK2 receptor agonist
-
GC30680
Gastrin/CCK antagonist 1
-
GC31592
GI 181771
-
GC10360
Lorglumide (sodium salt)
nonpeptidic antagonist of the CCK A receptor
-
GC31382
Loxiglumide (CR-1505)
-
GC36610
Mini Gastrin I, human
-
GC36611
Mini Gastrin I, human TFA
-
GC19258
Nastorazepide
Nastorazepide (Z-360) is a selective, orally available, 1,5-benzodiazepine-derivative gastrin/cholecystokinin 2 (CCK-2) receptor antagonist with potential antineoplastic activity.
-
GC32776
Pentagastrin (ICI-50123)
-
GC36976
Proglumide
-
GC11012
Proglumide sodium salt
Non-selective cholecystokinin (CCK) antagonist
-
GC31407
Sograzepide (Netazepide)
-
GC14258
SR 27897
CCK1 receptor antagonist
-
GC31477
Tarazepide